CRISPR and gene editing approaches in prostate cancer: Clinical applications and therapeutic potential.
- DOI
- 10.1016/j.critrevonc.2026.105610
- Published
- 2026 Sep 20
- Container
- Critical reviews in oncology/hematology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.critrevonc.2026.105610,
title = {CRISPR and gene editing approaches in prostate cancer: Clinical applications and therapeutic potential.},
author = {Patel V and Singh P and Dutta SP and Pande S and Langstang R and Kushwaha A},
year = {2026},
journal = {Critical reviews in oncology/hematology},
doi = {10.1016/j.critrevonc.2026.105610},
url = {https://doi.org/10.1016/j.critrevonc.2026.105610}
}RIS
TY - JOUR TI - CRISPR and gene editing approaches in prostate cancer: Clinical applications and therapeutic potential. AU - Patel V AU - Singh P AU - Dutta SP AU - Pande S AU - Langstang R AU - Kushwaha A PY - 2026 JO - Critical reviews in oncology/hematology DO - 10.1016/j.critrevonc.2026.105610 UR - https://doi.org/10.1016/j.critrevonc.2026.105610 ER -
APA
V, P., P, S., SP, D., S, P., R, L., & A, K. (2026). CRISPR and gene editing approaches in prostate cancer: Clinical applications and therapeutic potential.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2026.105610
Source records
- pubmed · retrieved 2026-09-25T23:26:58.088Z
- europe-pmc · retrieved 2026-09-25T23:26:58.096Z